Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Healthcare Biotechnology
Hemostemix Inc. is an autologous stem cell therapy platform company. The Company has developed, patented, and is scaling and selling autologous (patient’s own) blood-based stem cell therapies that include angiogenic cell precursors (ACP-01), later neural cell precursors (NCP-01), and cardiomyocyte cell precursors (CCP-01). It holds 91 patents on the derivation of three stem cell lineages from... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:HEM)

Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share

Newsfile 6 days ago

Hemostemix at Invest Stuttgart

Newsfile 10 days ago

Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio

Newsfile April 23, 2025

Hemostemix's Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial

Newsfile March 17, 2025

Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

Newsfile March 6, 2025

Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture

Newsfile March 5, 2025

RETRANSMISSION: Hemostemix Licenses CytoImmune's BioReactor Technologies

Newsfile February 20, 2025

Hemostemix Licenses CytoImmune's BioReactor Technologies

Newsfile February 19, 2025

Hemostemix Provides Corporate Update

Newsfile February 13, 2025
View More News ››

Opinion & Analysis (TSXV:HEM)

Shaping the Future of Regenerative Medicine Today

Dave Jackson February 11, 2021

Hemostemix Founder: A Man with a Compassionate Heart

Featured Submission December 15, 2020

Shaping the Future of Medicine by Delivering Regenerative Medicines

Dave Jackson December 9, 2020
View More Opinion ››

Bullboard Posts (TSXV:HEM)

RE:Vascular Dementia Phase one begins.. with NASDAQ AI Company

Amazing find. It matches the nr the company put out that everyone read on 3/6/25. 
KevinOleary - April 5, 2025

Vascular Dementia Phase one begins.. with NASDAQ AI Company

https://www.newsfilecorp.com/release/243458
loaddumper - March 6, 2025

RE:It’s alive!

Wow....looks like it's falling back into the ashes, huh, EMENEMENIMROD?
Peladawn - March 2, 2025

RE:RE:They should be at 90%

Hey Fox.....judging by the fact you haven't been pumping HEM now for the last couple years, my guess is you bought in at about .20...
Peladawn - March 2, 2025

Moonshot.

HEM seems to be coming back to earth. No reaching the moon just yet.
Donwaan - February 19, 2025

RE:My take on these recent developments.......

Couldn't agree more! Exciting times ahead!
SEAGEBE - January 19, 2025
View more Bullboard ››

Spirit Blockchain Capital Inc.

Spirit Blockchain Capital Inc.

Spirit Blockchain Capital Inc. is an investment company focused on blockchain industry. Through its operational business line ...
View More »